These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25128267)

  • 1. Focusing on potential sources of glucose fluctuations in type 1 and type 2 diabetes: which kind of patient, what kind of glycemic variability and which confounding factors?
    Chilelli NC; Sartore G; Lapolla A
    Diabetes Res Clin Pract; 2014 Oct; 106(1):e1-2. PubMed ID: 25128267
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycemic patterns detected by CGMS in patients with diabetes mellitus in the United Arab Emirates.
    Lessan NG; Abdullah A; Hassan H; Nasir Q; Athamneh S
    Diabetes Technol Ther; 2006 Aug; 8(4):513-5. PubMed ID: 16939376
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous Glucose Monitoring in 2018.
    Bode BW; Battelino T
    Diabetes Technol Ther; 2019 Feb; 21(S1):S13-S31. PubMed ID: 30785326
    [No Abstract]   [Full Text] [Related]  

  • 4. Pre-exercise blood glucose affects glycemic variation of aerobic exercise in patients with type 2 diabetes treated with continuous subcutaneous insulin infusion.
    Hu Y; Zhang DF; Dai L; Li Z; Li HQ; Li FF; Liu BL; Sun XJ; Ye L; He K; Ma JH
    Diabetes Res Clin Pract; 2018 Jul; 141():98-105. PubMed ID: 29730390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of alternate site testing--comparing arm and finger blood glucose results in glucose dynamic states.
    Lock JP; Szuts EZ; Malomo KJ; Anagnostopoulos A; Rao S
    Diabetes Technol Ther; 2002; 4(1):87-9. PubMed ID: 12017426
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects.
    Paty BW; Senior PA; Lakey JR; Shapiro AM; Ryan EA
    Diabetes Technol Ther; 2006 Apr; 8(2):165-73. PubMed ID: 16734547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in applying diabetes technology to clinical care.
    Peters AL
    Diabetes Technol Ther; 2012 Oct; 14(10):849-50. PubMed ID: 23013199
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood glucose self-monitoring. Part I: the gear.
    Dubois W
    Diabetes Self Manag; 2014; 31(3):14, 16-9. PubMed ID: 24941502
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous Glucose Monitoring in 2017.
    Battelino T; Bode BW
    Diabetes Technol Ther; 2018 Feb; 20(S1):S13-S29. PubMed ID: 29437476
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T).
    Levy JC; Davies MJ; Holman RR;
    Diabetes Res Clin Pract; 2017 Sep; 131():161-168. PubMed ID: 28750219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous glucose monitoring: physiologic and pathophysiologic significance.
    Ionescu-Tîrgovişte C; Guja C; Ioacără S; Dumitrescu D; Tomescu I
    Rom J Intern Med; 2004; 42(2):381-93. PubMed ID: 15529628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coefficient of variation of R-R interval closely correlates with glycemic variability assessed by continuous glucose monitoring in insulin-depleted patients with type 1 diabetes.
    Iwasaki S; Kozawa J; Fukui K; Iwahashi H; Imagawa A; Shimomura I
    Diabetes Res Clin Pract; 2015 Aug; 109(2):397-403. PubMed ID: 26047681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Minder A
    Ther Umsch; 2017; 74(8):441-444. PubMed ID: 29461150
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased glycemic variability at the onset and during progression of type 2 diabetes-commentary.
    Rodbard D
    Diabetes Technol Ther; 2013 Jun; 15(6):445-7. PubMed ID: 23731442
    [No Abstract]   [Full Text] [Related]  

  • 15. [Insulin therapy and self-monitoring of blood glucose: therapeutic management and recommendations].
    Hanaire-Broutin H
    Diabetes Metab; 2003 Apr; 29(2 Pt 2):S21-5. PubMed ID: 12746622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in diabetes thinking: a critical summary and analysis of keystone 2009.
    Rotenstein L; Close KL
    Diabetes Technol Ther; 2010 Feb; 12(2):167-71. PubMed ID: 20105048
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges.
    Wood A; O'Neal D; Furler J; Ekinci EI
    Intern Med J; 2018 May; 48(5):499-508. PubMed ID: 29464891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose monitoring in the acutely ill patient with diabetes mellitus.
    Quinn L
    Crit Care Nurs Q; 1998 Nov; 21(3):85-96. PubMed ID: 10646424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of diabetes in children and young people: summary of updated NICE guidance.
    Beckles ZL; Edge JA; Mugglestone MA; Murphy MS; Wales JK;
    BMJ; 2016 Jan; 352():i139. PubMed ID: 26819261
    [No Abstract]   [Full Text] [Related]  

  • 20. Self-monitoring of blood glucose in patients with type 2 diabetics not using insulin.
    Cordts S
    Am Fam Physician; 2012 May; 85(9):866-7. PubMed ID: 22612181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.